Panbela TherapeuticsのIPO年
Panbela TherapeuticsのIPO年は何ですか。
Panbela Therapeutics Inc.のIPO年は2020です。
IPO年の定義は何ですか。
新規公開株 (IPO)は、企業の株式を通常は機関投資家に販売し、順番に証券取引所で一般市民に販売する株式公開の一種です。
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
NASDAQのセクタHealth CareにおけるIPO年の企業と比べるPanbela Therapeutics
Panbela Therapeuticsは何をしますか。
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Panbela Therapeuticsと類似のipo年
- Acusensus LtdのIPO年は2019です。
- Grayscale Ethereum Trust (ETH)のIPO年は2019です。
- Powerwrap LtdのIPO年は2019です。
- PowerwrapのIPO年は2019です。
- National Rural Utilities CooperのIPO年は2019です。
- Listed Funds TrustのIPO年は2019です。
- Panbela TherapeuticsのIPO年は2020です。
- Globally Local TechnologiesのIPO年は2021です。
- uniQure N.VのIPO年は2021です。
- Trustpilot plcのIPO年は2021です。
- IQVIAのIPO年は2021です。
- ACTIA S.AのIPO年は2021です。
- RemarkのIPO年は2021です。